40 related articles for article (PubMed ID: 19756420)
1. Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.
Priest ND; Dauer LT; Hoel DG
PLoS One; 2020; 15(4):e0232597. PubMed ID: 32353063
[TBL] [Abstract][Full Text] [Related]
2. Ra-224 activity, half-life, and 241 keV gamma ray absolute emission intensity: A NIST-NPL bilateral comparison.
Bergeron DE; Collins SM; Pibida L; Cessna JT; Fitzgerald R; Zimmerman BE; Ivanov P; Keightley JD; Napoli E
Appl Radiat Isot; 2021 Apr; 170():109572. PubMed ID: 33461017
[TBL] [Abstract][Full Text] [Related]
3. A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?
de Kruijff RM; Wolterbeek HT; Denkova AG
Pharmaceuticals (Basel); 2015 Jun; 8(2):321-36. PubMed ID: 26066613
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224.
Wick RR; Nekolla EA; Gaubitz M; Schulte TL
Rheumatology (Oxford); 2008 Jun; 47(6):855-9. PubMed ID: 18390588
[TBL] [Abstract][Full Text] [Related]
5. Late effects in ankylosing spondylitis patients treated with 224Ra.
Wick RR; Nekolla EA; Gössner W; Kellerer AM
Radiat Res; 1999 Dec; 152(6 Suppl):S8-S11. PubMed ID: 10564926
[TBL] [Abstract][Full Text] [Related]
6. Malignancies in patients treated with high doses of radium-224.
Nekolla EA; Kellerer AM; Kuse-Isingschulte M; Eder E; Spiess H
Radiat Res; 1999 Dec; 152(6 Suppl):S3-7. PubMed ID: 10564925
[TBL] [Abstract][Full Text] [Related]
7. Life-span study on late effects of 224Ra in children and adults.
Spiess H
Health Phys; 2010 Sep; 99(3):286-91. PubMed ID: 20699688
[TBL] [Abstract][Full Text] [Related]
8. Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man.
Wick RR; Atkinson MJ; Nekolla EA
Radiat Environ Biophys; 2009 Aug; 48(3):287-94. PubMed ID: 19475414
[TBL] [Abstract][Full Text] [Related]
9. [Long-term investigation of the risk of malignant diseases following intravenous radium-224 treatment for ankylosing spondylitis].
Schulte TL; Nekolla EA; Wick RR
Strahlenther Onkol; 2009 Sep; 185(9):549-56. PubMed ID: 19756420
[TBL] [Abstract][Full Text] [Related]
10. Peteosthor - a medical disaster due to Radium-224A personal recollection.
Spiess H
Radiat Environ Biophys; 2002 Sep; 41(3):163-72. PubMed ID: 12373324
[TBL] [Abstract][Full Text] [Related]
11. Estimation of cancer risks from radiotherapy of benign diseases.
Trott KR; Kamprad F
Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma following intravenous thorium X therapy].
Madeya S; Labenz J; Breining H; Peitz U; Korth J; Börsch G
Dtsch Med Wochenschr; 1994 May; 119(18):653-6. PubMed ID: 8187611
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
